Requirements for Adaptive Designs in Clinical Trials

Posted 01 June 2009 | By

The interest in adaptive trial design has rapidly increased within the pharmaceutical industry in recent years. Furthermore, regulatory authorities are promoting adaptive design features in order to support "more efficient trial design," which was defined as one of the goals of the US Food and Drug Administration's Critical Path Initiative.1


Regulatory Focus newsletters

All the biggest regulatory news and happenings.